相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sorafenib in Advanced Hepatocellular Carcinoma Hypertension as a Potential Surrogate Marker for Efficacy
Bassam Estfan et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2013)
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
M. Scartozzi et al.
BRITISH JOURNAL OF CANCER (2013)
Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis
Jun Cai et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2012)
Safety and effectiveness of sorafenib in patients with hepatocellular carcinoma in clinical practice
Giovan Giuseppe Di Costanzo et al.
DIGESTIVE AND LIVER DISEASE (2012)
The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease
Hebah H. Al-Habboubi et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2012)
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma
Nicola Personeni et al.
JOURNAL OF HEPATOLOGY (2012)
Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients
Mario Scartozzi et al.
PLOS ONE (2012)
Evolving strategies for the treatment of hepatocellular carcinoma: From clinical-guided to molecularly-taylored therapeutic options
Luca Faloppi et al.
CANCER TREATMENT REVIEWS (2011)
Field-Practice Study of Sorafenib Therapy for Hepatocellular Carcinoma: A Prospective Multicenter Study in Italy
Massimo Iavarone et al.
HEPATOLOGY (2011)
Predicting the treatment effect of sorafenib using serum angiogenesis markers in patients with hepatocellular carcinoma
Koji Miyahara et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Genetics of VEGF Serum Variation in Human Isolated Populations of Cilento: Importance of VEGF Polymorphisms
Daniela Ruggiero et al.
PLOS ONE (2011)
The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer
T. F. Hansen et al.
PHARMACOGENOMICS JOURNAL (2011)
VEGF-460T→C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma
M-H Chen et al.
PHARMACOGENOMICS JOURNAL (2011)
The changing pattern of epidemiology in hepatocellular carcinoma
Helena Nordenstedt et al.
DIGESTIVE AND LIVER DISEASE (2010)
The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer
K. D. Steffensen et al.
GYNECOLOGIC ONCOLOGY (2010)
Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib
Bruno Vincenzi et al.
ONCOLOGIST (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer
Torben Frostrup Hansen et al.
VIRCHOWS ARCHIV (2010)
Vascular Endothelial Growth Factor Polymorphisms: Role in Response and Toxicity of Tyrosine Kinase Inhibitors
Susan A. J. Vaziri et al.
CURRENT ONCOLOGY REPORTS (2010)
Phase 2 Open-label Study of Single-agent Sorafenib in Treating Advanced Hepatocellular Carcinoma in a Hepatitis B-endemic Asian Population
Thomas Yau et al.
CANCER (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
Robert C. Kane et al.
ONCOLOGIST (2009)
Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer
Jean-Louis Formento et al.
PHARMACOGENOMICS (2009)
Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
Anne M. Schultheis et al.
CLINICAL CANCER RESEARCH (2008)
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100
Bryan P. Schneider et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Vascular endothelial growth factor gene polymorphisms and serum levels in Behcet's disease
M. Kamoun et al.
TISSUE ANTIGENS (2008)
Pharmacogenetics of EGFR and VEGP inhibition
Jan Pander et al.
DRUG DISCOVERY TODAY (2007)
Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS
R. Zhai et al.
THORAX (2007)
The role of vascular endothelial growth factor (VEGF) in inflammatory bowel disease
Marc Ferrante et al.
INFLAMMATORY BOWEL DISEASES (2006)
Transcriptional regulation of the Vascular Endothelial Growth Factor gene -: a concert of activating factors
G Pagès et al.
CARDIOVASCULAR RESEARCH (2005)
VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer
MI Koukourakis et al.
LUNG CANCER (2004)
A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk
P Krippl et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes
T Awata et al.
DIABETES (2002)
A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels
W Renner et al.
JOURNAL OF VASCULAR RESEARCH (2000)
Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: Correlation with variation in VEGF protein production
CJ Watson et al.
CYTOKINE (2000)
分享论文
